# FDA Inspection 1321216 - Vitalant - June 09, 2026

Source: https://www.keypedia.com/records/fda_inspections/vitalant/da5e8ab1-63da-412f-85c8-74271469ac14
Source feed: FDA_Inspections

> FDA Inspection 1321216 for Vitalant on June 09, 2026. Classification: N/A.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1321216
- Company Name: Vitalant
- Inspection Date: 2026-06-09
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Minneapolis District Office

## Related Documents

- [FDA Inspection 1178692 - 2022-08-10](https://www.keypedia.com/records/fda_inspections/vitalant/9c93efc8-8b78-450d-b820-361889737ea8)
- [FDA Inspection 1178692 - 2022-08-10](https://www.keypedia.com/records/fda_inspections/vitalant/2733c766-7664-4b03-86e0-58bc45bce95e)
- [FDA Inspection 1063370 - 2018-07-25](https://www.keypedia.com/records/fda_inspections/vitalant/42a216f5-fc42-4d4b-8026-8a3a35d5cfd7)
- [FDA Inspection 971653 - 2016-04-20](https://www.keypedia.com/records/fda_inspections/vitalant/2b910786-416d-4263-bae4-fe21e986e66f)
- [FDA Inspection 878175 - 2014-04-30](https://www.keypedia.com/records/fda_inspections/vitalant/3c93630c-67f5-4fb1-b7f7-157a9f704187)

Company: https://www.keypedia.com/companies/vitalant/b9b4314c-fc2b-424f-b2a5-b643bc2bd996

Office: https://www.keypedia.com/offices/minneapolis-district-office/c79fc8dc-f884-48fc-ba80-2947f662511d